Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside

Cancer Immunology, Immunotherapy

Volumn 52, Issue 3, 2003, Pages 145-154

  Basak, Saroj ^a   Birebent, Brigitte ^a   Purev, Enkhtsetseg ^a   Somasundaram, Rajasekharan ^a   Maruyama, Haruhiko ^a   Zaloudik, Jan ^a   Swoboda, Rolf ^a   Strittmatter, Wolfgang ^d   Li, Weiping ^a   Luckenbach, Albrecht ^d   Song, Hong ^a   Li, Jian ^a   Sproesser, Katrin ^a   Guerry, Dupont ^b   Nair, Sridar ^a   Furukawa, Koichi ^c   Herlyn, Dorothee ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NAGASAKI UNIVERSITY   (Japan)

^d NONE

Author keywords

Anti idiotypic antibody; Cellular immunity; GD2 ganglioside; Melanoma

Indexed keywords

GANGLIOSIDE GD2; GANGLIOSIDE GD3; IDIOTYPIC ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG SPECIFICITY; HUMAN; HUMAN CELL; MELANOMA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0037382967     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0340-0     Document Type: Article

References (60)

1. b-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells. Eur J Immunol 26:544
2. Adluri S, Helling F, Ogata S, Zhang S, Itzkowitz SH, Lloyd KO, Livingston PO (1995) Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients. Cancer Immunol Immunother 41:185
3. Agadjanyan M, Luo P, Westerink MAJ, Carey LA, Hutchins W, Steplewski Z, Weiner DB, Kieber-Emmons T (1997) Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nature Biotechnol 15:547
4. Albertini MR, Hank JA, Schiller JH, Khorsand M, Borchert AA, Gan J, Bechhofer R, Storer B, Reisfeld RA, Sondel PM (1997) Phase IB trial of chimeric anti-disialoganglioside antibody plus interleukin-2 for melanoma patients. Clin Cancer Res 3:1277
5. Cahan LD, Irie RF, Singh R, Cassidenti A, Paulson JC (1982) Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci USA 79:7629
6. 3 by human soft-tissue sarcomas. Cancer 70:633
7. D3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody. J Clin Invest 88:186
8. 2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5:1430
9. D2 anti-idiotypic monoclonal antibodies. Int J Cancer 54:499
10. D2 antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. J Clin Oncol 16:3053
11. Diakun KR, Matta KL (1989) Synthetic antigens as immunogens: part III. Specificity analysis of an anti-anti-idiotypic antibody to a carbohydrate tumor-associated antigen. J Immunol 142:2037
12. Distler JJ, Jourdian GW (1973) The purification and properties of β-galactosidase from bovine testes. J Biol Chem 248:6772
13. Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM (1997) Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer 80:317
14. - T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity. J Immunol 133:1671
15. Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO (1989) Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Cancer Res 49:191
16. Galli-Stampino J, Meinjohamns E, Frische K, Meldal M, Jensen T, Werdelin O, Mouristen S (1997) T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determined glycopeptide immunogenicity. Cancer Res 57:3214
17. Grant SC, Kostakoglu L, Kris MG, Yeh SD, Larson SM, Finn RD, Oettgen HF, Cheung NV (1996). Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial. Eur J Nucl Med 23:145
18. Handgretinger R, Anderson K, Lang P, Dopfer R, Klingebiel T, Schrappe M, Reuland P, Gillies SD, Reisfeld RA, Neithammer D (1995) A phase I study of human/mouse chimeric anti-ganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer 31A:261
19. M3-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. Proc Natl Acad Sci USA 91:10455
20. Haurum JS, Arsequell G, Lellouch AC, Wong SYC, Dwek RA, McMichael AJ, Elliott T (1994) Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. J Exp Med 180:739
21. 2-specific monoclonal antibody 3F8 in human osteosarcoma. Cancer Res 47:5377
22. Henningsson CM, Selvaraj S, MacLean GD, Suresh MR, Noujaim AA, Longenecker BM (1987) T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo. Cancer Immunol Immunother 25:231
23. Herlyn D, Ross AH, Koprowski H (1986) Anti-idiotypic antibodies bear the internal image of a human tumor antigen. Science 232:100
24. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH, KoprowskiH (1985) Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 45:5670
25. Hersey P, MacDonald M, Werkman H (1988) Western blot analysis of antigens on melanoma cells recognized by cytotoxic T cells. J Natl Cancer Inst 80:826
26. Houghton AN, Taormina MC, Ikeda H, Watanabe T, Oettgen HF, Old LJ (1980) Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. Proc Natl Acad Sci USA 77:4260
27. Hutchins W, Adkins A, Kieber-Emmons T, Westerink MAJ (1996) Molecular characterization of a monoclonal antibody produced in response to a group-C meningococcal polysaccharide peptide mimic. Mol Immunol 33:503
28. Iliopoulos D, Ernst C, Steplewski Z, Jambrosic JA, Rodeck U, Herlyn M, Clark WH Jr, Koprowski H, Herlyn D (1989) Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J Natl Cancer Inst 81:440
29. Irie RF, Morton DL (1986) Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2. Proc Natl Acad Sci USA 83:8694
30. Jacob L, Somasundaram R, Smith W, Monos D, Basak S, Marincola F, Pereira S, Herlyn D (1997) Cytotoxic T cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells. Int J Cancer 71:325
31. Jensen T, Hansen P, Galli-Stampino L, Mouritsen S, Frische K, Meinjohanns E, Meldal M, Werdelin O (1997) Carbohydrate and peptide specificity of MHC class II-restricted T-cell hybridomas raised against an O-glycosylated self peptide. J Immunol 158:3769
32. 3 ganglioside. Int J Cancer 76:345
33. Kieber-Emmons T, Luo P, Qiu J-P, Agadjanyan M, Carey L, Hutchins W, Westerink MAI, Steplewski Z (1997) Peptide mimicry of adenocarcinoma-associated carbohydrate antigens. Hybridoma 16:3
34. Kitamura K, Stockert E, Garin-Chesa P, Welt S, Lloyd KO, Armour KL, Wallace TP, Harris WJ, Carr FJ, Old LJ (1994) Specificity analysis of blood group Lewis-y [Le(y)] antibodies generated against synthetic and natural Le(y) determinants. Proc Natl Acad Sci USA 91:12957
35. Koprowski H, Steplewski Z, Herlyn D, Herlyn M (1978) Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 75:3405
36. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P (1979) Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 5:957
37. Livingston PO (1995) Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines. Immunol Rev 145:147
38. Maruyama H, Benden A, Li W, Zaloudik J, Koido T, Taupin JL, Acres B, Somasundaram R, Prewett M, Herlyn D (1996) Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733. Int J Cancer 65:547
39. Michaëlsson E, Malmström V, Reis S, Engström A, Burkhardt H, Holmdahl R (1994) T-cell recognition of carbohydrates on type II collagen. J Exp Med 180:745
40. Murali R, Kieber-Emmons T (1997) Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody. J Mol Recogn 10:269
41. Portoukalian J, Carrel S, Doré J-F, Rumke P (1991) Humoral immune response in disease-free advanced melanoma patients after vaccination with melanoma-associated gangliosides. Int J Cancer 49:893
42. Ross AH, Herlyn M, Ernst CS, Guerry G, Bennicelli J, Ghrist BFD, Atkinson B, Koprowski H (1984) Immunoassay for melanoma-associated proteoglycan in sera of the patients using monoclonal and polyclonal antibodies. Cancer Res 44:4642
43. Saarinen UM, Sariola H, Hovi L (1991) Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue. Am J Pediatr Hematol Oncol 13:315
44. Saleh MN, Khazaeli MB, Wheeler RH, Allen L, Tilden AB, Grizzle W, Reisfeld RA, Yu AL, Gillies SD, LoBuglio AF (1992) Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma. Hum Anti Hybrid 3:19
45. Saleh MN, Khazaeli MB, Wheeler RH, Dropcho E, Liu T, Urist M, Miller DM, Lawson S, Dixon P, Russell CH, LuBuglio AF (1992) Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res 52:4342
46. Saleh MN, Stapleton JD, Khazaeli MB, LoBuglio AF (1993) Generation of a human anti-idiotypic antibody that mimics the GD2 antigen. J Immunol 151:3390
47. Smith RH, Messner P, Lamontagne LR, Sleytr UB, Unger FM (1993) Induction of T-cell immunity to oligosaccharide antigens immobilized on crystalline bacterial surface layers (S-layers). Vaccine 11:919
48. Stein K, Soderstrom T (1984) Neonatal administration of idiotype or anti-idiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med 160:1001
49. Sugiyama T, Imai K, Ono A, Takayama Y, Tsujisaki M, Taki T, Hinoda Y, Yachi A (1991) Conformational structure of a monoclonal anti-idiotypic antibody to the monoclonal zanti-adenocarcinoma-associated carbohydrate antibody YH206. J Immunol 146:3097
50. Suzuki M, Iwashiro M, Takatsuki F, Kuribayashi K, Hamuro J (1994) Reconstitution of anti-tumor effects of lentinan in nude mice: roles of delayed-type hypersensititivty reaction triggered by CD4-positive T cell clone in the infiltration of effector cells into tumor. Jpn J Cancer Res 85:409
51. Tai T, Cahan LD, Tsuchida T, Saxton RE, Irie RF, Morton DL (1985) Immunogenicity of melanoma-associated gangliosides in cancer patients. Int J Cancer 35:607
52. Takahashi H, Herlyn D, Atkinson B, Powe J, Rodeck U, Alavi A, Bruce D, Koprowski H (1987) Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor. Cancer Res 47:3847
53. Takahashi H, Belser PH, Atkinson BF, Sela BA, Ross AH, Biegel J, Emanuel B, Sutton L, Koprowski H, Herlyn D (1990) Monoclonal antibody-dependent cell-mediated cytotoxicity against human malignant gliomas. Neurosurgery 27:97
54. D3 antigens and antibody-mediated cytotoxicity. Cancer Res 47:1229
55. Tsuyuoka K, Yago K, Hirashima K, Ando S, Hanai N, Saito H, Yamasaki KM, Takahashi K, Fukuda Y, Nakao K, Kannagi R (1996) Characterization of a T-cell line specific to an anti-Id antibody related to the carbohydrate antigen, sialyl SSEA-1, and the immunodominant T-cell antigenic site of the antibody. J Immunol 157:661
56. Watanabe T, Pukel CS, Takeyama H, Lloyd KO, Shiku H, Li LT, Travassos LR, Oettgen HF, Old LJ (1982) Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med 156:1884
57. Westerink MAJ, Giardina PC, Apicella MA, Kieber-Emmons T (1995) Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc Natl Acad Sci USA 92:4021
58. Yamamoto S, Yamamoto T, Saxton RE, Hoon DSB, Irie RF (1990) Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3. J Natl Cancer Inst 82:1757
59. Zhang H, Zhang S, Cheung N-KV, Ragupathi G, Livingston PO (1998) Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases. Cancer Res 58:2844
60. D2 oligosaccharide: target for cytotoxic T lymphocytes. J Exp Med 182:67